Position in ABBV
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$95,024,860
+$2,469,045 QoQ
Shares Held
436,916
+7.9% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $457,189,468 across 19 Drug Manufacturers - General names. ABBV ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
629,201 | $153,801,892 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
436,916 | $95,024,860 | |
| 3 | LLY |
ELI LILLY & Co
|
91,946 | $84,569,172 | |
| 4 | MRK |
Merck & Co., Inc.
|
305,398 | $36,736,325 | |
| 5 | AMGN |
Amgen Inc
|
76,905 | $27,059,024 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
244,135 | $14,806,787 | |
| 7 | PFE |
Pfizer Inc
|
472,519 | $13,268,333 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
75,160 | $10,475,049 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,024,860 | 436,916 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $92,555,815 | 405,076 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $82,242,544 | 355,198 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $63,507,284 | 342,136 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $57,007,249 | 272,085 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $48,010,630 | 270,178 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $49,158,301 | 248,928 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $38,402,298 | 223,894 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $39,614,762 | 217,544 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,166,967 | 207,569 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $25,948,364 | 174,080 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $24,014,275 | 178,240 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $28,667,794 | 179,882 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,033,236 | 179,650 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $24,276,575 | 180,885 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $27,323,131 | 178,396 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $31,284,798 | 192,985 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $26,152,780 | 193,152 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $20,144,291 | 186,746 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $19,318,999 | 171,511 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $16,180,405 | 149,514 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,039,726 | 121,696 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,680,446 | 110,520 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $10,099,678 | 102,869 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,038,965 | 92,387 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||